CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference18 articles.
1. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J Clin Oncol,2002
2. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis;Bristow;Gynecol Oncol,2009
3. CA125 and the detection of recurrent ovarian cancer;Bast;Cancer,2010
4. Defining progression of ovarian carcinoma during follow-up according to CA125: a North Thames Ovary Group Study;Rustin;Ann Oncol,1996
5. Use of CA125 to define progression of ovarian cancer in patients with persistently elevated levels;Rustin;J Clin Oncol,2001
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined aqupla, paclitaxel liposome, and docetaxel treatment: survival and biomarker outcomes in recurrent ovarian cancer patients;Frontiers in Oncology;2024-06-17
2. New Progress of CA125 Surveillance in Diagnosis and Treatment of Ovarian Cancer;Journal of Biosciences and Medicines;2024
3. Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies;Cancer Biomarkers;2023-06-08
4. Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies;2023-02-09
5. The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity;Diagnostics;2022-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3